crinecerfont 50 MG Oral Capsule [Crenessity]
crinecerfont
RxCUI: 2701405
What the CMS Formulary Data Shows for crinecerfont 50 MG Oral Capsule [Crenessity]
Per the CMS 2026 Part D formulary file, crinecerfont 50 MG Oral Capsule [Crenessity] (RxNorm concept RXCUI 2701405, generic name crinecerfont) appears on 16 distinct formulary files spanning 175 Medicare Part D plan offerings - 3.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to crinecerfont 50 MG Oral Capsule [Crenessity] depends on utilization management as much as tier placement: 87.5% of covering formularies require prior authorization. 0% require step therapy. 62.5% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry crinecerfont 50 MG Oral Capsule [Crenessity] today.
Coverage Details
- Formularies covering
- 16
- Plans covering
- 175
- Coverage rate
- 3.5%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 87.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 62.5% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering crinecerfont 50 MG Oral Capsule [Crenessity]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is crinecerfont 50 MG Oral Capsule [Crenessity] covered by Medicare Part D?
Yes, crinecerfont 50 MG Oral Capsule [Crenessity] is covered by 175 Medicare Part D plans (3.5% of all Part D formularies).
What tier is crinecerfont 50 MG Oral Capsule [Crenessity] on Medicare Part D plans?
crinecerfont 50 MG Oral Capsule [Crenessity] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does crinecerfont 50 MG Oral Capsule [Crenessity] require prior authorization?
87.5% of Part D formularies require prior authorization for crinecerfont 50 MG Oral Capsule [Crenessity]. Step therapy: 0%. Quantity limits: 62.5%.
Read our methodology - how this data is sourced, computed, and verified.